BT8009-100 phase I/II study of the safety, pharmacokinetics, & preliminary clinical activity of BT8009 in patients with Nectin-4 expressing advanced malignancies 来自 科研支点 喜欢 0 阅读量: 122 作者: M Mckean,JC Bendell,DP Petrylak,TB Powles,GP Sonpavde,A Dickson,L Dosunmu,MG Hennessy,P...